Ship Healthcare (3360) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Sep, 2025Executive summary
Net sales rose 6.0% year-over-year to ¥155,219 million in Q1 FY2025, with operating profit down 8.8% to ¥3,502 million and profit attributable to owners of parent up 2.2% to ¥3,065 million.
Business performance was in line with expectations, supported by project progress in Total Pack Produce and ongoing execution of the medium-term management plan.
The Japanese economy showed moderate recovery, but uncertainty persists due to inflation and yen depreciation.
Financial highlights
Operating profit decreased 8.8% year-over-year to ¥3,502 million; ordinary profit fell 3.5% to ¥4,485 million.
Net income per share was ¥32.49, up from ¥31.78 in the prior year.
Comprehensive income dropped 37.6% year-over-year to ¥3,365 million.
Total assets at quarter-end were ¥377,014 million, down ¥9,805 million from the previous fiscal year-end.
Equity capital ratio improved to 36.7%, up 0.6 percentage points from the previous year-end.
Outlook and guidance
Full-year net sales forecast remains at ¥640,000 million, with operating profit projected at ¥26,000 million and profit attributable to owners of parent at ¥15,000 million.
No changes to previously announced financial forecasts; business performance is progressing as planned.
Latest events from Ship Healthcare
- Net sales up 6.1% to ¥522,415m, but profit fell on higher costs and non-recurring expenses.3360
Q3 20266 Feb 2026 - Net sales rose 7.5% YoY to ¥333.4B, with mixed segment results and steady full-year guidance.3360
Q2 202614 Nov 2025 - Net sales rose 4.5% YoY, but profits fell on project timing and costs; full-year outlook unchanged.3360
Q2 20258 Sep 2025 - Net sales and profit attributable to owners of parent surged, while segment margins varied.3360
Q3 20258 Sep 2025 - Net sales rose 7.5% YoY to ¥678.2B, with profit growth and ambitious 2030 targets set.3360
Q4 20258 Sep 2025 - Net sales rose 5.2% YoY, but profits fell due to project timing and rising costs.3360
Q1 20268 Sep 2025